Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Millennials can benefit from specific wealth-building money habits. Discover strategies tailored for a successful financial future.
13,978 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Bitcoin ETFs pulled about $2 billion in net inflows in April, the strongest monthly total so far this year. May opene...
A new Microsoft AI diffusion map shows ordinary Americans across states are adopting AI at surprising rates, not just...
A Minnesota nonprofit leader was sentenced to nearly 42 years for orchestrating a $250 million fraud tied to pandemic...
Quantum stocks have been front and center as grants and hype push prices higher. This guide explains why infleqtion s...
As global tensions rise, borrowing costs and lenders' risk appetites shift. This guide explains why the housing marke...
The Federal Reserve is weighing a major shift to give crypto firms direct access to core settlement rails, potentiall...
Analysts say XRP would require a rare confluence of market, regulatory, and macro factors to hit $200 per token. Here...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
Rising debt servicing is taking an ever-larger bite of federal receipts, with a key watchdog warning the trend could ...
In May 2026, data show Ethereum as the leading real-world settlement layer amid a growing tokenized-asset market. Inv...
A news-driven swing in Ondas stock sparked investor curiosity. This guide breaks down the catalysts, what it means fo...